Pratt Collard Advisory Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
M&T Bank
MTB
|
+$388K |
| 2 |
Ovintiv
OVV
|
+$269K |
| 3 |
Linde
LIN
|
+$206K |
| 4 |
Ball Corp
BALL
|
+$200K |
| 5 |
Dover
DOV
|
+$195K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$696K |
| 2 |
Procter & Gamble
PG
|
+$522K |
| 3 |
Boeing
BA
|
+$506K |
| 4 |
iShares US Pharmaceuticals ETF
IHE
|
+$323K |
| 5 |
Amazon
AMZN
|
+$298K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Staples | 17.66% |
| 3 | Healthcare | 16.97% |
| 4 | Financials | 13.96% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Dover
DOV
$27.5B
| $204K | 0.16% |
+2,032
| New | +$195K |
|
102
Charter Communications
CHTR
$16.9B
| $200K | 0.16% |
+505
| New | +$189K |
|
103
CSX Corp
CSX
$93B
| $200K | 0.16% |
7,770
-1,500
| -16% | -$38.6K |
|
|
OBE
104
Obsidian Energy
OBE
$678M
| $179K | 0.14% |
150,286
+32,412
| +27% | +$58.5K |
|
105
Microvision
MVIS
$85.7M
| $20K | 0.02% |
25,125
| – | – |
|
106
Air Products & Chemicals
APD
$66.8B
| – | – |
-1,080
| Closed | -$206K |
|
107
BOK Financial
BOKF
$8.57B
| – | – |
-3,010
| Closed | -$245K |
|
108
ConocoPhillips
COP
$145B
| – | – |
-3,225
| Closed | -$215K |
|
109
DuPont de Nemours
DD
$18.7B
| – | – |
-2,070
| Closed | -$279K |
|
110
Fortive
FTV
$17.7B
| – | – |
-3,877
| Closed | -$205K |
|
111
Hewlett Packard
HPE
$62.4B
| – | – |
-10,150
| Closed | -$157K |
|
|
112
iShares US Pharmaceuticals ETF
IHE
$1.48B
| – | – |
-6,300
| Closed | -$323K |
|
113
UnitedHealth
UNH
$383B
| – | – |
-877
| Closed | -$217K |
|
Similar funds
Pratt Collard Advisory Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Pratt Collard Advisory Partners held 113 positions worth $127M, up 1.3% from $125M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Pratt Collard Advisory Partners withdrew a net $4.19M in Q2 2019, closing 8 positions and reducing 50 holdings. Its most notable exit was iShares US Pharmaceuticals ETF, an estimated $323K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Pratt Collard Advisory Partners opened a new position in Linde worth $221K.
- Pratt Collard Advisory Partners's largest Q2 2019 buy was Linde: 1,099 shares worth $221K.
- Pratt Collard Advisory Partners added most to M&T Bank in Q2 2019, an estimated $388K increase.
- Pratt Collard Advisory Partners's biggest Q2 2019 reduction was Blackstone, cutting an estimated $696K.
- Pratt Collard Advisory Partners fully exited iShares US Pharmaceuticals ETF in Q2 2019, selling an estimated $323K.
- Pratt Collard Advisory Partners's ten largest holdings make up 38% of its $127M portfolio in Q2 2019.
- Pratt Collard Advisory Partners opened 4 new positions and closed 8 in Q2 2019.
- Pratt Collard Advisory Partners's portfolio value rose 1.3% quarter-over-quarter to $127M.
Based on Pratt Collard Advisory Partners's 13F filing for Q2 2019, filed 16 Jul 2019.